Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcription profiling of Mouse lymphoma L5178Y cells treated with Benzo(a)pyrene diolepoxide I (BDPE) - ILSI-HESI Genotoxicity Study -BDPE

ABSTRACT: Mouse lymphoma L5178Y cells are treated with Benzo(a)pyrene diolepoxide I (BDPE) [CAS:58917-67-2;CHEBI:30614] and harvested at 4 and 24 hours for analysis.

ORGANISM(S): Mus musculus

SUBMITTER: Syril Pettit

PROVIDER: E-TOXM-2 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Transcription profiling of mouse lymphoma L5178Y cells treated with Cisplatin - ILSI-HESI Genotoxicity Study - Cisplatin

Project description:Mouse lymphoma L5178Y cells are treated with Cisplatin [CAS:15663-27-1;CHEBI:27899] and harvested at 4 and 24 hours for analysis.

2004-02-13 | E-TOXM-4 | biostudies-arrayexpress

Transcription profiling of mouse lymphoma L5178Y cells treated with Hydroxyurea - ILSI-HESI Genotox Study - Hydroxyurea

Project description:Mouse lymphoma L5178Y cells are treated with Hydroxyurea [CAS:127-07-1;CHEBI:5816] and harvested at 4 and 24 hours for analysis.

2006-02-13 | E-TOXM-6 | biostudies-arrayexpress

Transcription profiling of mouse lymphoma L5178Y cells treated with Mitomycin C - ILSI-HESI Genotoxicity Study - Mitomycin

Project description:Mouse lymphoma L5178Y cells are treated with Mitomycin C [CAS:50-07-7;CHEBI:27504] and harvested at 4 and 24 hours for analysis.

2004-05-13 | E-TOXM-8 | biostudies-arrayexpress

Transcription profiling of mouse lymphoma L5178Y cells treated with Taxol (Paclitaxel) ILSI-HESI Genotoxicity Study - Taxol

Project description:Mouse lymphoma L5178Y cells are treated with Taxol (Paclitaxel) [CAS:33069-62-4;CHEBI:7887] and harvested at 4 and 24 hours for analysis.

2004-02-13 | E-TOXM-9 | biostudies-arrayexpress

Transcription profiling of mouse lymphoma L5178Y cells treated with Bleomycin- ILSI-HESI Genotoxicity Study - Bleomycin

Project description:Mouse lymphoma L5178Y cells are treated with Bleomycin [CAS:11056-06-7;CHEBI:3139] and harvested at 4 and 24 hours for analysis.

2004-06-13 | E-TOXM-3 | biostudies-arrayexpress

Transcription profiling of mouse lymphoma L5178Y cells treated with 4-NitroQuinoline N-Oxide (4-NQO) ILSI-HESI Genotoxicity Study - 4-NQO

Project description:Mouse lymphoma L5178Y cells are treated with 4-NitroQuinoline N-Oxide (4-NQO) [CAS:56-57-5;CHEBI:16907] and harvested at 4 and 24 hours for analysis.

2006-02-13 | E-TOXM-1 | biostudies-arrayexpress

Transcription profiling of mouse lymphoma L5178Y and Human TK6 cells treated with Methylmethane Sulfonate ILSI-HESI Genotoxicity Study - MMS

Project description:Mouse lymphoma L5178Y and Human TK6 cells are treated with Methylmethane Sulfonate [CAS:66-27-3;CHEBI:25255] and harvested a 4 and 24 hours for analysis.

2005-02-13 | E-TOXM-7 | biostudies-arrayexpress

Transcription profiling of mouse lymphoma L5178Y cells treated with EtoposideILSI-HESI Genotoxicity Study - Etoposide

Project description:Mouse lymphoma L5178Y cells are treated with Etoposide [CAS:33419-42-0;CHEBI:4911] and harvested a 4 and 24 hours for analysis.

2004-02-13 | E-TOXM-5 | biostudies-arrayexpress

Transcription profiling of mouse lymphoma L5178Y cells treated with Hydroxyurea

Project description:The multi-lab International Life Sciences Institute (ILSI) project on the application of genomics to risk assessment offered the unique opportunity to investigate the influence of variability within and between laboratories on identifying biologically relevant gene expression changes. We assessed the gene expression profiles of mouse lymphoma L5178Y cells treated with hydroxyurea (HU) in three independent studies from two different laboratories, Sanofi-Aventis and Procter and Gamble. Cells were dosed for 4 hr and harvested immediately at the end of the treatment or after a 20-hr recovery period. Cytotoxicity and genotoxicity were evaluated by standard assays. Statistical analysis of these data revealed that, while gene expression responses to HU treatment were markedly different at 4 hr vs. 24 hr, there was otherwise a consistent pattern of dose-response across the three studies. Therefore, the studies were merged and each time point was evaluated separately. At 4 hr, we identified 173 (P lt 0.0001) dose-responsive genes with a common trend in all three studies. These were mainly associated with the cell cycle, DNA repair and DNA metabolism, and in particular, the intra-S and G2/M phase checkpoints. At 24 hr, we identified 434 dose-responsive genes common across studies. These genes were involved in lymphocyte-specific activities and the activation of apoptosis via the caspase cascade. Our results show that despite inter-laboratory variability, combining the three studies in a single statistical analysis identifies more significantly-modulated genes than in any of the individual studies, due to improved statistical sensitivity. The genes identified in our study provide information that is relevant to HU biology.

2005-08-25 | E-TOXM-17 | biostudies-arrayexpress

Transcription profiling of rat kidney exposed to different doses of Cisplatin- ILSI-HESI NephroToxicity Study - Cisplatin

Project description:Evaluation and comparison of biological responses of rats and gene expression responses of the kidney in rats exposed to different doses of Cisplatin [CAS:15663-27-1;CHEBI:27899]

2007-01-10 | E-TOXM-11 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data